Skip to main content

and
  1. Article

    Open Access

    i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists

    The ability to leverage antibodies to agonize disease relevant biological pathways has tremendous potential for clinical investigation. Yet while antibodies have been successful as antagonists, immune mediator...

    Matthew G. Romei, Brandon Leonard, Zachary B. Katz, Daniel Le in Nature Communications (2024)

  2. Article

    Open Access

    MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner

    One of the mechanisms by which tumors evade immune surveillance is through shedding of the major histocompatibility complex (MHC) class I chain-related protein A and B (MICA/B) from their cell surface. MICA/B ...

    Changchun Du, Jack Bevers III, Ryan Cook in Journal for ImmunoTherapy of Cancer (2019)

  3. Article

    Open Access

    A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies

    Outer membrane proteins (OMPs) in Gram-negative bacteria are essential for a number of cellular functions including nutrient transport and drug efflux. Escherichia coli BamA is an essential component of the OMP β...

    Rajesh Vij, Zhonghua Lin, Nancy Chiang, Jean-Michel Vernes in Scientific Reports (2018)

  4. Article

    Open Access

    Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system

    Rapid identification of residues that influence antibody expression and thermostability is often needed to move promising therapeutics into the clinic. To establish a method that can assess small expression di...

    T. Noelle Lombana, Michael Dillon, Jack Bevers III, Christoph Spiess in Scientific Reports (2015)